One-carbon therapeutics presents at Bio€quity 2022.

by admin
maj 17, 2022

CEO Ana Slipicevic present the MTHFD2 program and one-carbon therapeutics AB in the Hot Topic session at Bio€quity 2022 in Milan.

Rekommenderade artiklar

One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe

One-carbon therapeutics AB is discussing the ODIN trial with several

Our Founder Prof Thomas Helleday wins the Anders Jahre’s price in Medicine

Read the article here.

One-carbon therapeutics AB is moving into new offices

In preparation and expansion for the upcoming clinical trial, we

Menu bar